NMC sends communications to Medical Colleges on 218 more applications to start new PG medical courses, seat increase

Published On 2024-03-22 07:33 GMT   |   Update On 2024-03-22 12:40 GMT

New Delhi: The Medical Assessment and Rating Board (MARB) of the National Medical Commission (NMC) has issued communications on 218 more online applications for starting new PG medical courses and increase of PG seats for the academic year 2024-2025.Previously, the Apex Medical Commission had sent communications in different phases for more such applications through notices dated 11th March...

Login or Register to read the full article

New Delhi: The Medical Assessment and Rating Board (MARB) of the National Medical Commission (NMC) has issued communications on 218 more online applications for starting new PG medical courses and increase of PG seats for the academic year 2024-2025.

Previously, the Apex Medical Commission had sent communications in different phases for more such applications through notices dated 11th March 2024, 12th March 2024 and 15th March 2024. These communications have been sent through the email IDs (as mentioned in the online applications) to the concerned medical institutes/colleges for information and necessary action within the stipulated timeline.

The latest notice by NMC MARB, issued on 20.03.2024 mentioned, "In continuation of MARB’s Public Notice of even number dated 11th March 2024, 12th March 2024 and 15th March 2024 with reference to applications from medical institutions for start or increase of PG courses/seats, it is informed that communications in respect of 218 more online applications (for starting of New PG Medical courses and Increase of seats in PG Medical courses for the Academic Year : 2024-25) have been sent through the email IDs (as mentioned in online applications) to the Medical Institutions/Colleges concerned for information and necessary action by them within the stipulated timeline. A list containing application number of each of the aforesaid 218 more online applications is attached with this Public Notice for general information."

Medical Dialogues had earlier reported that MARB received a total of 1675 applications including 1010 applications for the start of PG courses and 665 applications for the increase of PG seats in existing medical colleges for the AY 2024-25.

Among these, NMC through its notice dated 11.04.2024, informed that a total number of 10 institutes had withdrawn their 34 applications for starting and increasing PG medical seats. Through the same notice, NMC informed that it had sent communications in respect of 204 online applications for starting or increase of PG medical seats to the concerned medical institutes for information and necessary action by them within the stipulated timeline.

Again, through other notices, NMC sent communications on more applications. Referring to these earlier communications, MARB mentioned in its notice dated 21.03.2024, "It may be recalled that vide MARB’s Public notice of even number dated 11th March 2024, 12th March 2024 & 15th March 2024, it was informed that communications in respect of 238 + 214 + 202 = 654 online PG Medical course applications had already been sent through the email IDs (as mentioned in online applications) to the Medical Institutions/Colleges concerned."

"Communications in respect of remaining applications received online will be sent in due course," NMC clarified.

Meanwhile, NMC had earlier clarified regarding the communications sent to the concerned applicant colleges and informed that the communications had been sent seeking deficient documents and information along with the submission of sworn affidavit.

To view the NMC notice, click on the link below:

Also Read: New PG medical courses or seat increase: NMC seeks submission of sworn affidavit, deficient documents, info from medical colleges

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News